DEFIANTE FARMACEUTICA, S.A. – Trademark Portfolio
Entity Type: 03
DEFIANTE FARMACEUTICA, S.A. holds 15 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 12 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 3 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include ABELCET and ONCASPAR. The owner is based in Funchal - Madeira.
Rua dos Ferreiros, 260
Funchal - Madeira P-9000-08 , PT
Showing of trademarks Trademarks
Trademark Classifications
DEFIANTE FARMACEUTICA, S.A.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Scientific and technological services; industrial analysis and research services
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Frequently Asked Questions
How many trademarks does DEFIANTE FARMACEUTICA, S.A. have?
DEFIANTE FARMACEUTICA, S.A. has 15 U.S. trademarks filed with the USPTO. Of these, 2 registered, 5 cancelled.
What trademark classes does DEFIANTE FARMACEUTICA, S.A. file in?
DEFIANTE FARMACEUTICA, S.A. files trademarks across 3 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are DEFIANTE FARMACEUTICA, S.A.'s most well-known trademarks?
DEFIANTE FARMACEUTICA, S.A.'s registered trademark portfolio includes well-known marks such as ABELCET and ONCASPAR. These are among 2 currently registered trademarks in the portfolio.
What is DEFIANTE FARMACEUTICA, S.A.'s trademark registration success rate?
DEFIANTE FARMACEUTICA, S.A. has a 29% trademark registration rate, with 2 out of 7 resolved applications resulting in successful registration. Currently, 0 applications are pending review.